Matches in Nanopublications for { ?s ?p "[We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1293912.RAB6bf0CGFrO48qIBb33agNw8eQ8xZutVVR4rc57AssjM130_assertion description "[We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293912.RAB6bf0CGFrO48qIBb33agNw8eQ8xZutVVR4rc57AssjM130_provenance.
- NP1293915.RAklxpcgYfJGv7k6sNJQzTLCxag6wzBxG-wkkMTkmbx4g130_assertion description "[We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293915.RAklxpcgYfJGv7k6sNJQzTLCxag6wzBxG-wkkMTkmbx4g130_provenance.
- NP1293911.RAzKhOgypJ1xkcfsXPgZyh5jH9eEaRcEkG5Zekml4paPU130_assertion description "[We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293911.RAzKhOgypJ1xkcfsXPgZyh5jH9eEaRcEkG5Zekml4paPU130_provenance.
- NP1293913.RA4cI2c1-19MMPQj8wTH69eeKSTPGUoNDKOllGNrvoTyI130_assertion description "[We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293913.RA4cI2c1-19MMPQj8wTH69eeKSTPGUoNDKOllGNrvoTyI130_provenance.